Skip to main content

HEALTH

  • Study: Use of Purell hand sanitizer reduced diarrhea and respiratory illness incidence among children

    AKRON, Ohio — Among children who took part in a recent study on the use of hand sanitizer in an environment with limited access to clean water, diarrhea cases were reduced by 30% and respiratory illnesses by more than 11%, GOJO Industries noted in a release issued Tuesday. 

    The University of Columbia study was reported in the June 2012 issue of Pan American Journal of Public Health. As part of the study, researchers monitored children's use of alcohol hand sanitizer in conjunction with education to help to reduce life-threatening infections.

  • Chicago Mayor takes opportunity to promote flu shots at Walgreens flagship grand opening

    CHICAGO — Chicago Mayor Rahm Emanuel on Tuesday joined representatives from Walgreens to celebrate the grand opening of a new Walgreens flagship store in the Bucktown-Wicker Park neighborhood on Tuesday afternoon, taking the opportunity to remind Chicagoans about the importance of getting a flu shot this season.

  • Bausch + Lomb introduces consumer-preferred cap design

    CHICAGO — Bausch + Lomb recently introduced a new consumer-preferred cap design across its Renu multi-purpose contact lens solution brand. 

    The design and overseal snap provides for an added ease of use, the company stated.  

    The Renu brand in July celebrated 25 years on the shelf. First introduced in 1987, the brand helped revolutionize the contact lens solution category as a daily, single-bottle contact lens care regimen.

  • CDC: Influenza season officially underway

    ATLANTA — The influenza season is officially underway as flu incidence is already above the national threshold, Thomas Frieden, director of the Centers for Disease Control and Prevention, told reporters during a teleconference Monday. "This is the earliest regular flu season we've had in nearly a decade, since the 2003-2004 flu season," he said. "That was an early and severe flu year, and while flu is always unpredictable, the early nature of the cases as well as the specific strains we're seeing suggest that this could be a bad flu year."

  • Westport Pharmaceuticals launches Zephrex-D, a tamper-resistant PSE formulation

    ST. LOUIS – Westport Pharmaceuticals on Tuesday launched Zephrex-D, a tamper-resistant pseudoephedrine-based decongestant that now is available in retail stores throughout the St. Louis region and the state of Missouri. 

  • Kowa Health Care America introduces two supplements to U.S. market

    LOS ANGELES — Kowa Health Care America recently launched two supplement products into the U.S. marketplace — NutriDiet, a diet aid, and Okinawa Life. 

    NutriDiet has been formulated to aid in the digestion of food and absorption of key nutrients necessary for internal balance. The formulation includes probiotics, prebiotics and green tea catechins in an effort to improve overall health. The combination helps to promote intestinal health, while assisting in burning fat to create a healthy weight balance.

  • Pfizer closes deal, sells nutrition business to Nestlé for $11.9 billion

    NEW YORK — Pfizer on Friday announced that it has completed the sale of its nutrition business to Nestlé for $11.9 billion in cash, following the conclusion of the required regulatory process in most markets. In certain countries where completion will be delayed due to ongoing regulatory review, Pfizer will continue to operate the business on an interim basis.

  • Diabetes drug appears to improve survival in women with ovarian cancer

    NEW YORK — Women with ovarian cancer and diabetes who took the generic diabetes drug metformin showed better survival rates than those who did not take the drug, according to a new study led by the Mayo Clinic.

    The study, published in the journal Cancer, enrolled 61 patients who took metformin and 178 who didn't. Of those who took the drug, 67% were surviving after five years, compared with 47% of those who didn't take it. Further analysis indicated that patients taking metformin were almost four times likelier to survive than those not taking it.

X
This ad will auto-close in 10 seconds